BAY14-2222 Continuous Infusion in Surgeries
NCT00606060
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia
Interventions
DRUG:
Kogenate (BAY14-2222)
Sponsor
Bayer